论文部分内容阅读
原发性肝癌是目前世界上致死率最高的恶性肿瘤之一,且发病率有逐年上升的趋势.血清肿瘤标志物对肝癌的早期诊断、肿瘤进展的监测、疗效判定、复发和患者生存率的判断具有重要意义,临床常用的实验室血清标志物有甲胎蛋白、异常凝血酶原、血清铁蛋白α-L岩藻糖苷酶、γ-谷氨酰转肽酶(GGT)及其同工酶、人高尔基蛋白73、磷脂酰肌醇蛋白聚糖-3、鳞状细胞癌抗原、铁蛋白及其酸性同工铁蛋白等.通过对这些实验室血清标志物检测,可以早期诊断肿瘤病变程度,并判定预后.
Primary liver cancer is one of the most malignant tumors in the world, and the incidence rate has been rising year by year. Serum tumor markers for the early diagnosis of liver cancer, monitoring of tumor progression, efficacy determination, recurrence and survival rate of patients Judgment is of great significance. Clinically used laboratory serum markers include alpha fetoprotein, abnormal prothrombin, serum ferritin alpha-L fucosidase, gamma-glutamyl transpeptidase (GGT) and its isoenzymes. , Human Golgi protein 73, Glypican-3, Squamous cell carcinoma antigen, Ferritin and its acidic isoferritin, etc. Through the detection of these laboratory serum markers, early diagnosis of tumor lesions can be made. And determine the prognosis.